Literature DB >> 7273377

Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines.

F H Messerli, E D Frohlich, D H Suarez, E Reisin, G R Dreslinski, F G Dunn, F E Cole.   

Abstract

The relationships between age, systemic and renal hemodynamics, circulating catecholamines (norepinephrine, epinephrine and dopamine) and intravascular volumes were studied in 38 normotensive subjects and in 77 patients with borderline essential hypertension. Borderline hypertensive patients had a higher cardiac index (p less than 0.02) and renal blood flow (p less than 0.05) than normotensive subjects if they were younger than 30 years of age, whereas in older patients no difference was observed. In contrast, total peripheral resistance was normal in young borderline hypertensive patients, but significantly increased (p less than 0.02) in patients older than age 40 years. Cardiac output (r = -0.28, p less than 0.01) and renal blood flow (r = -0.47, p less than 0.001) correlated inversely with age in the entire population and in both subgroups. Cardiac output also correlated closely with renal blood flow in all subjects (r = 0.45, p less than 0.001). Circulating norepinephrine levels increased with age (r = 0.25, p less than 0.05), whereas epinephrine concentration tended to decrease. Plasma and total blood volume correlated directly with cardiac output (r = 0.39, p less than 0.001) and inversely with peripheral resistance (r = -0.34, p less than 0.001). These data indicate that the hyperdynamic circulation (high cardiac output and renal blood flow) of borderline hypertension is found predominantly in patients younger than age 30 years. Older patients are characterized by an elevated total peripheral resistance and normal cardiac output. The age-dependent increase in circulating norepinephrine and decrease in epinephrine levels may participate in the shift of the hemodynamic profile from high-cardiac-output hypertension in the young to a high-arteriolar-resistance hypertension in the older patient.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273377     DOI: 10.1161/01.cir.64.4.760

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

Review 2.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 3.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 4.  Isolated Systolic Hypertension in Young and Middle-Aged Adults.

Authors:  Yuichiro Yano; Donald M Lloyd-Jones
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

5.  Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study.

Authors:  Yuichiro Yano; Jeremiah Stamler; Daniel B Garside; Martha L Daviglus; Stanley S Franklin; Mercedes R Carnethon; Kiang Liu; Philip Greenland; Donald M Lloyd-Jones
Journal:  J Am Coll Cardiol       Date:  2015-02-03       Impact factor: 24.094

6.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

7.  Acute lysyl oxidase inhibition alters microvascular function in normotensive but not hypertensive men and women.

Authors:  Daniel H Craighead; Huilei Wang; Lakshmi Santhanam; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

Review 8.  Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

Authors:  R W Piepho; K J Fendler
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

9.  Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.

Authors:  Uchechukwu K A Sampson; Todd L Edwards; Eiman Jahangir; Heather Munro; Minaba Wariboko; Mariam G Wassef; Sergio Fazio; George A Mensah; Edmond K Kabagambe; William J Blot; Loren Lipworth
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-12-23

Review 10.  Does anxiety or cardiovascular reactivity have a causal role in hypertension?

Authors:  R H Rosenman
Journal:  Integr Physiol Behav Sci       Date:  1991 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.